PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Sofonac
Presentation Product Chemical substance Chapter Items dispensed
Sofonac 5mg/2.5mg modified-release tablets
0407020AFBEADAC
Sofonac Oxycodone hydrochloride/naloxone hydrochloride Central Nervous System 1
Sofonac 10mg/5mg modified-release tablets
0407020AFBEAAAA
Sofonac Oxycodone hydrochloride/naloxone hydrochloride Central Nervous System No data available
Sofonac 20mg/10mg modified-release tablets
0407020AFBEABAB
Sofonac Oxycodone hydrochloride/naloxone hydrochloride Central Nervous System No data available
Sofonac 40mg/20mg modified-release tablets
0407020AFBEACAD
Sofonac Oxycodone hydrochloride/naloxone hydrochloride Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.